Showing results (1411-1420 of 1,519) with videos related to

Sort By:
Pageof 152
Journal of Ethnopharmacology|November 19, 2023
Terminalia chebula Retz. aqueous extract inhibits the Helicobacter pylori-induced inflammatory response by regulating the inflammasome signaling and ER-stress pathwayLing Ou, Heng-Rui Liu, Xiao-Yan Shi, et al.
Bone Marrow Transplantation|August 23, 2025
Leukemia stem cells for relapse prediction in AML patients receiving allografts: long-term follow-up of a prospective studySi-Qi Li, Lan-Ping Xu, Yu Wang, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|December 12, 2018
Allogeneic Hematopoietic Stem Cell Transplantation, Especially Haploidentical, May Improve Long-Term Survival for High-Risk Pediatric Patients with Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia in the Tyrosine Kinase Inhibitor EraYu-Juan Xue, Yi-Fei Cheng, Ai-Dong Lu, et al.
Bone Marrow Transplantation|January 19, 2019
Class I and II human leukocyte antibodies in pediatric haploidentical allograft candidates: prevalence and risk factorsMeng Lv, Shu-Zhen Zhai, Yu Wang, et al.
Frontiers in Pharmacology|March 17, 2023
The self-medication behaviors of residents and the factors related to the consideration of drug efficacy and safety-A cross-sectional study in ChinaPu Ge, Zi-Wei Zhang, Jin-Zi Zhang, et al.
Clinical Transplantation|November 22, 2020
The incidence, clinical outcome, and protective factors of mixed chimerism following hematopoietic stem cell transplantation for severe aplastic anemiaZheng-Li Xu, Yi-Fei Cheng, Yuan-Yuan Zhang, et al.
Journal of Hematology & Oncology|March 20, 2019
Early myeloid-derived suppressor cells (HLA-DR<sup>-</sup>/<sup>low</sup>CD33<sup>+</sup>CD16<sup>-</sup>) expanded by granulocyte colony-stimulating factor prevent acute graft-versus-host disease (GVHD) in humanized mouse and might contribute to lower GVHD in patients post allo-HSCTKe Wang, Meng Lv, Ying-Jun Chang, et al.
Bone Marrow Transplantation|August 22, 2018
The significance of peri-transplantation minimal residual disease assessed by multiparameter flow cytometry on outcomes for adult AML patients receiving haploidentical allograftsJing Liu, Rui Ma, Yan-Rong Liu, et al.
Cell Research|January 18, 2026
The AHCY-adenosine complex rewires mRNA methylation to enhance fatty acid biosynthesis and tumorigenesisKun Liao, Fen Cao, Chen Wei, et al.
British Journal of Haematology|September 28, 2024
Mega-dose decitabine conditioning and prophylactic donor lymphocyte infusion for patients with relapsed/refractory AML with active disease at the time of allogeneic haematopoietic cell transplantation: A multicenter prospective phase II studyMeng Lv, Chen-Hua Yan, Rui Ma, et al.
Pageof 152